Rapid test 2019-nCoV Total Immunoglobulins (V1210/V1230)

JAVASCRIPT DISABLED - This site works best with JavaScript enabled.

Rapid test 2019-nCoV Total Immunoglobulins (V1210/V1230)

Principle: Lateral flow method

Automation: No

Approvals: Currently Under approval by FDA, Pending CE IVD mark

Suitability: Medical teams, countries’ entry points, suitable for field use

Capital equipment required: No

Description:

Rapid test 2019-nCoV Total is a qualitative Lateral Flow test for the determination of IgA, IgM, and IgG antibodies against SARS-CoV-2 in human serum, plasma, or whole blood specimens.

Key Points:

Lateral flow in dip stick format available in 10 or 30 test sticks
Clinical Diagnostic Sensitivity (98.75%) and Clinical Diagnostic Specificity (100%)
Low procedure time: 10 min
Easy-to-use method, no need for equipment or special facilities
Visual interpretation of the results
Shelf Life: 12 months | Storage 4-30°C

Please note : Any products described on this page are for Research Use Only and not intended for clinical diagnostic procedures unless otherwise stated.

Areas:

Clinical

Tags: